TQ Quiz | Eyelid and Conjunctiva Growths & Degenerations – From Benign to Terrifying (Scottsdale 2024) by Events@optometricedu.com | Jan 30, 2024 | 2024 Scottsdale, TQ Courses | 0 comments "*" indicates required fields This field is hidden when viewing the form@{:35}This field is hidden when viewing the formDate (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent 60 days past date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date Difference (Hidden)1. What causes molluscum contagiosum?* A - Herpes simplex B - Herpes zoster C - Poxvirus D - Pseudomonas 2. Which of the following is caused by human papilloma virus and is sometimes referred to as a “common wart”?* A - Pyogenic granuloma B - Verruca vulgaris C - Epidermal inclusion cyst D - Seborrheic keratosis 3. Which of the following would be induced by UV exposure and has a low risk of converting to squamous cell carcinoma?* A - Actinic keratosis B - Milia C - Dermoid D - Acrochordon 4. Port wine stains may be associated with which of the following syndromes?* A - Treacher Collins B - Goldenhar C - Xeroderma pigmentosum D - Sturge Weber 5. Which of the following systemic drugs may be indicated in the management of capillary hemangiomas?* A - Propranolol B - Lisinopril C - Atorvastatin D - Metformin 6. Which of the following may be associated with hyperlipidemia?* A - Pyogenic granuloma B - Apocrine hidrocystoma C - Xanthelasma D - Syringoma 7. What is the most common malignant eyelid tumor?* A - Melanoma B - Basal cell carcinoma C - Nevus D - Ephelis 8. Which treatment has the highest cure rate for skin carcinoma?* A - Topical 5 fluorouracil B - Topical Mitomycin C C - Topical Imiquimod D - Moh’s surgery 9. Which skin cancer would be yellowish in appearance due to presence of lipids, and would be more common on the upper eyelids where the meibomian glands are more abundant?* A - Sebaceous cell carcinoma B - Basal cell carcinoma C - Squamous cell carcinoma D - Melanoma 10. Which skin cancer is the most lethal due to its high rate of metastasis and may begin as a pre-malignancy called Hutchinson’s freckle?* A - Sebaceous cell carcinoma B - Basal cell carcinoma C - Squamous cell carcinoma D - Melanoma 11. What is the best management for pseudomembranes in your patient with EKC?* A - Betadine B - Corticosteroid C - Removal with forceps D - Bandage contact lens 12. Which of the following treatments would be most effective for patients with conjunctivochalasis?* A - Cautery B - Corticosteroid C - Chelation D - Cryo 13. Lymphangiectasia treatment and permanent punctal closure can both be achieved with which of the following in-office devices:* A - YAG laser B - Argon laser C - High frequency radiowave D - Intense pulsed light 14. Which conjunctival condition may present as a salmon-pink lesion and is treated with external beam radiation therapy?* A - Orbital fat prolapse B - Conjunctivochalasis C - Pterygium D - Lymphoma 15. Which of the following is a benign tumor of the conjunctiva and is often associated with human papilloma virus?* A - Melanoma B - Squamous cell carcinoma C - Conjunctival papilloma D - Primary acquired melanosis 16. Non-invasive ocular surface squamous neoplasia (OSSN) may also be called:* A - Conjunctival intraepithelial neoplasia B - Melanosis C - Giant fornix syndrome D - Lymphoma 17. Which treatment would be most effective against ocular surface squamous neoplasia (OSSN)?* A - Antibiotic B - Corticosteroid C - 5-fluorouracil D - Betadine 18. Which unilateral pigmented conjunctival finding would most likely be a new onset pigmentation in elderly, fair skinned patients and has a risk of becoming melanoma?* A - Nevus B - Lymphoma C - Papilloma D - Primary acquired melanosis 19. Which of the following are signs of potential malignancy when evaluating pigmented conjunctival lesions?* A - Prominent feeder vessel B - Suddent growth or change in pigmentation C - Adult age development D - All of the above 20. What co-management would be recommended for patients with suspected melanoma?* A - Oncology B - Rheumatology C - Endocrinology D - Orthopedics Personal InformationName* First Last Email* Phone*OE Tracker #License #Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationPromotional CodeScottsdale 2024 - Eyelid and Conjunctiva Growths & Degenerations - From Benign to Terrifying | TQ Credit*After @{:59}, pricing will increase to $30. Price: (Past 60 Days) Scottsdale 2024 - Eyelid and Conjunctiva Growths & Degenerations - From Benign to Terrifying | TQ CreditThis course was presented over 60 days ago. Due to this late submission of TQ, your TQ credit price is $30. Price: Retake Discount Price: Promotional Discount Price: (Past 60 Days) Retake Discount Price: (Past 60 Days) Promotional Discount Price: Credit Card* This field is hidden when viewing the formCourse Information (HIDDEN)This field is hidden when viewing the formCourse Name (HIDDEN)This field is hidden when viewing the formRetake Code (HIDDEN)This field is hidden when viewing the formQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/)This field is hidden when viewing the formCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
